Today, we're joined by Ivan Kairatov, a biopharma expert at the forefront of medical technology and innovation. We will be exploring the development and implications of a groundbreaking machine learning model that is reshaping our understanding of insulin resistance. Our conversation will delve
The aftermath of a spinal cord injury unleashes a devastating and prolonged biological assault, where the secondary damage cascade often proves more destructive than the initial physical trauma. This secondary injury process is a complex storm of excessive reactive oxygen species, relentless
A comprehensive global analysis has uncovered a troubling paradox in the fight against early-onset gastric cancer, a form of the disease striking individuals under the age of 50. While worldwide mortality rates have been steadily decreasing for decades, this positive trend masks a deepening and
In the complex world of health and longevity, the simple advice to "eat better" often feels vague. To bring clarity to this crucial topic, we sat down with biopharma expert Ivan Kairatov, whose extensive background in research and development provides a unique lens on the interplay between diet,
For patients diagnosed with inoperable liver tumors, treatment options have often been limited, presenting a formidable challenge for both individuals and their medical teams. A new clinical trial, however, is offering a ray of hope by pioneering a therapy that brings the entire treatment
The battle against cancer is often depicted as a prolonged war of attrition, where treatments gradually weaken a tumor over time until it finally succumbs. But new research is uncovering a startling truth about ovarian cancer: the enemy’s most sophisticated defense shield may deploy the moment the
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87